Substance Abuse Intensive Outpatient Programs: Assessing the Evidence
Year: 2014
Type: article
Study design: Systematic Review
Abstract: OBJECTIVE: Substance abuse intensive outpatient programs (IOPs) are direct services for people with substance use disorders or co-occurring mental and substance use disorders who do not require medical detoxification or 24-hour supervision. IOPs are alternatives to inpatient and residential treatment. They are designed to establish psychosocial supports and facilitate relapse management and coping strategies. This review assessed the evidence base for IOPs. METHODS: Authors searched major databases: PubMed, PsycINFO, Applied Social Sciences Index and Abstracts, Sociological Abstracts, Social Services Abstracts, Published International Literature on Traumatic Stress, ERIC, and CINAHL. They identified 12 individual studies and one review published between 1995 and 2012. They chose from three levels of research evidence (high, moderate, and low) based on benchmarks for the number of studies and quality of their methodology. They also described evidence of service effectiveness. RESULTS: Based on the quality of trials, diversity of settings, and consistency of outcomes, the level of evidence for IOPs was rated high. Multiple randomized trials and naturalistic analyses that compared IOPs with inpatient or residential care found comparable outcomes. All studies reported reductions in alcohol and drug use. However, substantial variability in the operationalization of IOPs and outcome measures was apparent. CONCLUSIONS: IOPs are an important part of the continuum of care for substance use disorders. They are as effective as inpatient treatment for most individuals. Public and commercial health plans should consider IOP services as a covered health benefit. Standardization of the elements included in IOPs may improve their quality and effectiveness.
Source: Psychiatric Services
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1699305842, Western States Node of the National Drug Abuse Treatment Clinical Trials Network, Oregon's Coordinated Care Organizations Integrate Care for Drug Use Disorders, Integrating Addiction Treatment and Medical Care in a Commercial Health Plan, Oregon's Coordinated Care Organizations Integrate Care for Drug Use Disorders, Evaluating Coordinated Care Organizations, Methamphetamine Abuse Research Center, To Test A Payer/Treatment Agency Intervention to Increase Use of Buprenorphine, G8610618049
OpenAlex ID: W2018649381
